InvestorsHub Logo
Followers 6
Posts 2155
Boards Moderated 0
Alias Born 11/26/2014

Re: Thedrugguru post# 10420

Monday, 03/23/2015 11:27:59 AM

Monday, March 23, 2015 11:27:59 AM

Post# of 38634
Guru- I agree, the 5mg will add to the bottom line nicely. I suspect when that is approved(hopefully May) we can count on at least an average of $1.5M per quarter of Focalin XR sales and quite possibly more. Another ANDA approval will bring us to break even at our current burn rate. Lastly and most importantly Penna is the man! He is going to take Odidi's technology and translate it into revenue over the coming years.